Finnrick, an independent testing programme, publishes 13 assays for Baohua Dongnuo Biotechnology BHD: 12 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 1 did not. Most recent assay 13 Jul 2026.
Baohua Dongnuo Biotechnology BHD operates from China, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/baohua-dongnuo-biotechnology-bhd.
Baohua Dongnuo Biotechnology BHD sells to businesses rather than direct to researchers. It also produces and labels to order, so stock sold under other brand names may come from here.
In its own words: “Make sure to buy crypto before completing your order. Use exodus.com Dismiss”
Baohua Dongnuo Biotechnology BHD publishes 4 certificates of analysis on its site, all credited to Janoshik Analytical. The vendor chose which batches to publish, so those results do not tell you what is in the vial you receive. It advertises purity of 99%.
No prices are published. You have to ask before you can compare cost against another supplier. Payment is by cryptocurrency.
Worth knowing before you order: no card payments and consumer email only. Payment is limited to cryptocurrency. Neither route carries the chargeback protection a card payment gives you if an order never arrives or arrives wrong.
Site check: 4 certificates of analysis published; payment by cryptocurrency.
Baohua Dongnuo Biotechnology BHD is listed as active. Finnrick Grade B. Finnrick avg score: 7.2/10 across 6 samples (1 products). Good quality with consistent test results.
Baohua Dongnuo Biotechnology BHD holds independent lab grade B, assigned across 6 graded samples, average score 7.2/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 7 | 6 passed, 1 failed |
| Tirzepatide | 6 | 6 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | B (6 samples) |
| Average grader score | 7.2/10 |
| Vendor type | Research-use supplier |
These details were read from Baohua Dongnuo Biotechnology BHD's own website on 2026-08-17. Pages consulted:
Baohua Dongnuo Biotechnology BHD is listed as active and we hold 13 Finnrick assays (12 passing, 1 failing its purity threshold); 4 certificates of analysis published on its own site; an independent lab grade of B. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 13 assays for Baohua Dongnuo Biotechnology BHD: 12 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 1 did not. Most recent assay 13 Jul 2026.
Baohua Dongnuo Biotechnology BHD accepts Cryptocurrency. Cryptocurrency is the only option, which means no chargeback protection if an order goes wrong.
Similar vendors: Amino Asylum, Guangzhou Jeep Biotechnology JEEP, Noble Dragons, Peptide Partners, Lipeptides, Zhengzhou Lanyun, Orbitrex Peptides, Peptide Technologies.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Baoju Chemical Peptides Review, Barn Peptides Review, Bayoupep USA Review.